These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 11897593)

  • 1. Oxazolidinone antibiotics target the P site on Escherichia coli ribosomes.
    Aoki H; Ke L; Poppe SM; Poel TJ; Weaver EA; Gadwood RC; Thomas RC; Shinabarger DL; Ganoza MC
    Antimicrob Agents Chemother; 2002 Apr; 46(4):1080-5. PubMed ID: 11897593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance mutations in 23 S rRNA identify the site of action of the protein synthesis inhibitor linezolid in the ribosomal peptidyl transferase center.
    Kloss P; Xiong L; Shinabarger DL; Mankin AS
    J Mol Biol; 1999 Nov; 294(1):93-101. PubMed ID: 10556031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The oxazolidinone linezolid inhibits initiation of protein synthesis in bacteria.
    Swaney SM; Aoki H; Ganoza MC; Shinabarger DL
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3251-5. PubMed ID: 9835522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxazolidinone resistance mutations in 23S rRNA of Escherichia coli reveal the central region of domain V as the primary site of drug action.
    Xiong L; Kloss P; Douthwaite S; Andersen NM; Swaney S; Shinabarger DL; Mankin AS
    J Bacteriol; 2000 Oct; 182(19):5325-31. PubMed ID: 10986233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A proposed role for IF-3 and EF-T in maintaining the specificity of prokaryotic initiation complex formation.
    Ganoza MC; Cunningham C; Chung DG; Neilson T
    Mol Biol Rep; 1991 Feb; 15(1):33-8. PubMed ID: 1875917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. R chi-01, a new family of oxazolidinones that overcome ribosome-based linezolid resistance.
    Skripkin E; McConnell TS; DeVito J; Lawrence L; Ippolito JA; Duffy EM; Sutcliffe J; Franceschi F
    Antimicrob Agents Chemother; 2008 Oct; 52(10):3550-7. PubMed ID: 18663023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of action of oxazolidinones: effects of linezolid and eperezolid on translation reactions.
    Shinabarger DL; Marotti KR; Murray RW; Lin AH; Melchior EP; Swaney SM; Dunyak DS; Demyan WF; Buysse JM
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2132-6. PubMed ID: 9333037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ribosomal RNA is the target for oxazolidinones, a novel class of translational inhibitors.
    Matassova NB; Rodnina MV; Endermann R; Kroll HP; Pleiss U; Wild H; Wintermeyer W
    RNA; 1999 Jul; 5(7):939-46. PubMed ID: 10411137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis of translation inhibition by cadazolid, a novel quinoxolidinone antibiotic.
    Scaiola A; Leibundgut M; Boehringer D; Caspers P; Bur D; Locher HH; Rueedi G; Ritz D
    Sci Rep; 2019 Apr; 9(1):5634. PubMed ID: 30948752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The oxazolidinone antibiotics perturb the ribosomal peptidyl-transferase center and effect tRNA positioning.
    Wilson DN; Schluenzen F; Harms JM; Starosta AL; Connell SR; Fucini P
    Proc Natl Acad Sci U S A; 2008 Sep; 105(36):13339-44. PubMed ID: 18757750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition by thiopeptin of bacterial protein synthesis.
    Liou YF; Kinoshita T; Tanaka N
    Jpn J Microbiol; 1976 Jun; 20(3):233-40. PubMed ID: 787605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxazolidinones mechanism of action: inhibition of the first peptide bond formation.
    Patel U; Yan YP; Hobbs FW; Kaczmarczyk J; Slee AM; Pompliano DL; Kurilla MG; Bobkova EV
    J Biol Chem; 2001 Oct; 276(40):37199-205. PubMed ID: 11483595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of elongation factor G GTPase activity by the ribosomal state. The effects of initiation factors and differentially bound tRNA, aminoacyl-tRNA, and peptidyl-tRNA.
    Voigt J; Nagel K
    J Biol Chem; 1993 Jan; 268(1):100-6. PubMed ID: 8416917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catalytic properties of mutant 23 S ribosomes resistant to oxazolidinones.
    Bobkova EV; Yan YP; Jordan DB; Kurilla MG; Pompliano DL
    J Biol Chem; 2003 Mar; 278(11):9802-7. PubMed ID: 12645571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of action of DuP 721: inhibition of an early event during initiation of protein synthesis.
    Eustice DC; Feldman PA; Zajac I; Slee AM
    Antimicrob Agents Chemother; 1988 Aug; 32(8):1218-22. PubMed ID: 2461163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The site of action of oxazolidinone antibiotics in living bacteria and in human mitochondria.
    Leach KL; Swaney SM; Colca JR; McDonald WG; Blinn JR; Thomasco LM; Gadwood RC; Shinabarger D; Xiong L; Mankin AS
    Mol Cell; 2007 May; 26(3):393-402. PubMed ID: 17499045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linezolid and tiamulin cross-resistance in Staphylococcus aureus mediated by point mutations in the peptidyl transferase center.
    Miller K; Dunsmore CJ; Fishwick CW; Chopra I
    Antimicrob Agents Chemother; 2008 May; 52(5):1737-42. PubMed ID: 18180348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between non-formylated initiator Met-tRNA(fMet) and the ribosomal A-site from Escherichia coli.
    Hansen PK; Clark BF; Petersen HU
    Biochimie; 1987 Aug; 69(8):871-7. PubMed ID: 2447956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formation of the first peptide bond: the structure of EF-P bound to the 70S ribosome.
    Blaha G; Stanley RE; Steitz TA
    Science; 2009 Aug; 325(5943):966-70. PubMed ID: 19696344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late events in translation initiation. Adjustment of fMet-tRNA in the ribosomal P-site.
    La Teana A; Pon CL; Gualerzi CO
    J Mol Biol; 1996 Mar; 256(4):667-75. PubMed ID: 8642589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.